TY - JOUR
T1 - Can the diagnosis of NF1 be excluded clinically? A lack of pigmentary findings in families with spinal neurofibromatosis demonstrates a limitation of clinical diagnosis
AU - Evans, Gareth
AU - Wright, Emma M M Burkitt
AU - Sach, Emma
AU - Sharif, Saba
AU - Quarrell, Oliver
AU - Carroll, Thomas
AU - Whitehouse, Richard W.
AU - Upadhyaya, Meena
AU - Huson, Susan M.
AU - Evans, D. Gareth R
PY - 2013
Y1 - 2013
N2 - Background: Consensus clinical diagnostic criteria for neurofibromatosis type I (NF1) include café-au-lait macules and skinfold freckling. The former are frequently the earliest manifestation of NF1, and as such are of particular significance when assessing young children at risk of the condition. A phenotype of predominantly spinal neurofibromatosis has been identified in a small minority of families with NF1, often in association with a relative or absolute lack of cutaneous manifestations. An association with splicing and missense mutations has previously been reported for spinal neurofibromatosis, but on the basis of molecular results in only a few families. Method: Patients with spinal NF1 were identified through the Manchester nationally commissioned service for complex NF1. Results: Five families with spinal NF1 were identified, with a broad spectrum of NF1 mutations, providing further evidence that this phenotype may arise in association with any genre of mutation in this gene. Pigmentary manifestations were absent or very mild in affected individuals. Several further affected individuals, some with extensive spinal root tumours, were ascertained when additional family members were assessed. Conclusions: Clinical NF1 consensus criteria cannot be used to exclude the diagnosis of spinal NF1, especially in childhood. This emphasises the importance of molecular confirmation in individuals and families with atypical presentations of NF1.
AB - Background: Consensus clinical diagnostic criteria for neurofibromatosis type I (NF1) include café-au-lait macules and skinfold freckling. The former are frequently the earliest manifestation of NF1, and as such are of particular significance when assessing young children at risk of the condition. A phenotype of predominantly spinal neurofibromatosis has been identified in a small minority of families with NF1, often in association with a relative or absolute lack of cutaneous manifestations. An association with splicing and missense mutations has previously been reported for spinal neurofibromatosis, but on the basis of molecular results in only a few families. Method: Patients with spinal NF1 were identified through the Manchester nationally commissioned service for complex NF1. Results: Five families with spinal NF1 were identified, with a broad spectrum of NF1 mutations, providing further evidence that this phenotype may arise in association with any genre of mutation in this gene. Pigmentary manifestations were absent or very mild in affected individuals. Several further affected individuals, some with extensive spinal root tumours, were ascertained when additional family members were assessed. Conclusions: Clinical NF1 consensus criteria cannot be used to exclude the diagnosis of spinal NF1, especially in childhood. This emphasises the importance of molecular confirmation in individuals and families with atypical presentations of NF1.
KW - Clinical genetics
KW - Dermatology
KW - Genetics
KW - Other neurology
U2 - 10.1136/jmedgenet-2013-101648
DO - 10.1136/jmedgenet-2013-101648
M3 - Article
C2 - 23812910
SN - 1468-6244
VL - 50
SP - 606
EP - 613
JO - Journal of Medical Genetics
JF - Journal of Medical Genetics
IS - 9
ER -